Catalyst Wire Dossier Catalyst Wire Dossier

UGN-101

· UroGen Pharma Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UGN-101, covering 2020-05-07 to 2020-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of UGN-101 in Recurrent Patients [Phase 3]

See pricing